Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19443656 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant
Condition: Cytomegalovirus Infections
Intervention: Biological: CMV CTL infusion

Indicates status has not been verified in more than two years